The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 20, 2018

Filed:

Jan. 28, 2014
Applicants:

Hector L. Lopez, Cream Ridge, NJ (US);

Timothy N. Ziegenfuss, Chardon, OH (US);

Inventors:

Hector L. Lopez, Cream Ridge, NJ (US);

Timothy N. Ziegenfuss, Chardon, OH (US);

Assignee:

Other;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/00 (2006.01); A61K 47/48 (2006.01); A61K 31/197 (2006.01); A61K 33/06 (2006.01); A61K 36/69 (2006.01); A61K 36/882 (2006.01); A61K 36/37 (2006.01); A61K 36/725 (2006.01); A61K 45/06 (2006.01); A61K 31/198 (2006.01); A23L 33/175 (2016.01); A61K 47/54 (2017.01); A61K 47/55 (2017.01);
U.S. Cl.
CPC ...
A61K 47/481 (2013.01); A23L 33/175 (2016.08); A61K 31/197 (2013.01); A61K 31/198 (2013.01); A61K 33/06 (2013.01); A61K 36/37 (2013.01); A61K 36/69 (2013.01); A61K 36/725 (2013.01); A61K 36/882 (2013.01); A61K 45/06 (2013.01); A61K 47/542 (2017.08); A61K 47/55 (2017.08); A23V 2002/00 (2013.01);
Abstract

The present invention relates in some aspects to compositions (e.g., pharmaceutical, nutritional compositions, etc.), formulations, and food or beverage products comprising, consisting essentially of, or consisting of (a) β-alanine or a derivative of β-alanine, and (b) at least one agent that inhibits the N-methyl D-aspartate (NMDA) pathway or a pathway which converges downstream with the NMDA pathway. The compositions, formulations, and food or beverage products are useful for enhancing physical performance, reducing β-alanine-induced paraesthesia, and improving tolerance and compliance to higher doses of β-alanine, thereby reducing the length of time it takes to achieve peak effect of β-alanine, and increasing the magnitude of peak effect on physical performance in a human or animal.


Find Patent Forward Citations

Loading…